Abivax SA Sponsored ADR (ABVX)
(Delayed Data from NSDQ)
$70.02 USD
+0.93 (1.35%)
Updated Aug 7, 2025 04:00 PM ET
After-Market: $70.14 +0.12 (0.17%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Abivax SA Sponsored ADR's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ABVX 70.02 +0.93(1.35%)
Will ABVX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ABVX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ABVX
Wall Street Analysts See a 360.53% Upside in Abivax SA Sponsored ADR (ABVX): Can the Stock Really Move This High?
Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year?
ABVX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Think Abivax SA Sponsored ADR (ABVX) Could Surge 427.9%: Read This Before Placing a Bet
Here's Why Abivax SA Sponsored ADR (ABVX) is Poised for a Turnaround After Losing -19.81% in 4 Weeks
Is Abivax SA Sponsored ADR (ABVX) Outperforming Other Medical Stocks This Year?
Other News for ABVX
Abivax (ABVX) Target Price Raised to $112 by Piper Sandler | ABVX Stock News
Abivax price target raised by $42 at Piper Sandler, here's why
Abivax (ABVX) Receives Boosted Price Target from Piper Sandler
Abivax SA (ABVX) Closes $747.5 Million Public Offering | ABVX stock news
Abivax Announces Closing of $747.5 Million Public Offering | ABVX Stock News